Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 21.264.223,22, with a 24-hour trading volume of Rp 136,94B. The asset's market cap is Rp 18,96P, after moving -0.02% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 21.302.166,79, with a tokenized market cap of Rp 825,98B and a 24-hour trading volume of Rp 39,27B. The tokenized asset has moved 1.80% in the past 24 hours.